Regeneron and Sanofi: FDA Approves Dupixent® as First Treatment for Eosinophilic Esophagitis
May 23, 2022
0
Regeneron Pharmaceuticals and Sanofi Announce FDA Approval of Dupixent® Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that the U.S. FDA has approved Dupixent (dupilumab . . . This content is for paid subscribers. Please click here to subscribe or here to log in.